Genetic Structure and Expression of the Surface Glycoprotein GP82, the Main Adhesin of Trypanosoma cruzi Metacyclic Trypomastigotes by Ceridorio Correa, Paulo Roberto et al.
Hindawi Publishing Corporation
The Scientific World Journal
Volume 2013, Article ID 156734, 11 pages
http://dx.doi.org/10.1155/2013/156734
Review Article
Genetic Structure and Expression of
the Surface Glycoprotein GP82, the Main Adhesin of
Trypanosoma cruzi Metacyclic Trypomastigotes
Paulo Roberto Ceridorio Correa, Esteban Mauricio Cordero, Luciana Girotto Gentil,
Ethel Bayer-Santos, and José Franco da Silveira
Departamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de Sa˜o Paulo,
Rua Botucatu 862, 04023-062 Sa˜o Paulo, SP, Brazil
Correspondence should be addressed to Jose´ Franco da Silveira; jose.franco@unifesp.br
Received 7 December 2012; Accepted 30 December 2012
Academic Editors: S. Amaral Gonc¸alves da Silva, P. M. L. Dutra, P. Grellier, and J. Martins de Santana
Copyright © 2013 Paulo Roberto Ceridorio Correa et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
T. cruzi improves the likelihood of invading or adapting to the host through its capacity to present a large repertoire of surface
molecules. The metacyclic stage-specific surface glycoprotein GP82 has been implicated in host cell invasion. GP82 is encoded
by multiple genes from the trans-sialidase superfamily. GP82 shows a modular organization, with some variation of N-terminal
region flanking a conserved central core where the binding sites to the mammalian cell and gastric mucin are located.The function
of GP82 as adhesin in host cell invasion process could expose the protein to an intense conservative and selective pressure. GP82 is
a GPI-anchored surface protein, synthesized as a 70 kDa precursor devoid of N-linked sugars. GPI-minus variants accumulate in
the ER indicating that GPI anchor acts as a forward transport signal for progressing along the secretory pathway as suggested for
T. cruzimucins. It has been demonstrated that the expression of GP82 is constitutive and may be regulated at post-transcriptional
level, for instance, at translational level and/or mRNA stabilization. GP82 mRNAs are mobilized to polysomes and consequently
translated, but only in metacyclic trypomastigotes. Analysis of transgenic parasites indicates that the mechanism regulating GP82
expression involves multiple elements in the 3󸀠UTR.
1. Introduction
Trypanosoma cruzi is a protozoan parasite that causes Chagas
disease, also called American trypanosomiasis, a debilitating
and incurable disease affecting millions of people in Latin
America. The life cycle of T. cruzi has multiple develop-
mental stages: two in the invertebrate vector (triatomine
hematophagous insects) and two in the vertebrate hosts.
The infective forms are the trypomastigote stages found in
the bloodstream of mammalian hosts and the metacyclic
trypomastigotes present in the digestive tract of triatomines.
Metacyclic trypomastigotes when eliminated in the feces of
the triatomine can initiate the infection of mammalian hosts
by invading a variety of cell types. They express a stage-
specific surface glycoprotein of 82 kDa (GP82) involved in
host cell invasion that has no counterpart in bloodstream
trypomastigotes [1–4]. GP82 is the major cell adhesion
molecule of metacyclic forms that induces the activation of
Ca2+ signaling cascades, leading to host cell cytoskeleton
rearrangement and recruitment of lysosomes at the site
of parasite entry, events required for the formation of the
parasitophorous vacuole, and parasite internalization [1, 2, 5–
8]. In this paper, we will mainly focus on the genetic structure
of GP82 family and regulation of its expression by post-
transcriptional control mechanisms.
2. Structure of GP82 Gene
The GP82 glycoprotein was first identified in the cellular
surface of metacyclic forms by the monoclonal antibody
Mab3F6 generated by immunization of mice with intact,
2 The Scientific World Journal
1 302010 40 706050 80 90
100 130120110 140 170160150 180
190 220210200 230 260250240 270
280 310300290 320 350340330 360
370 400390380 410 420 450440430 460
470 500490480P4P3
P3
P8P7 510 540530520 550
560 590580570 600 630620610 640
650 680670660 690 720710700 731
5.4G6 
C03
R31
JI8
5.4G6
CO3
R31
JI8
5.4G6
C03
R31
JI8
5.4G
CO3 
R31
JI8
5.4G6
C03
R31
JI8
5.4G6
C03
R31
JI8
5.4G6
C03
R31
JI8
5.4G6
C03
R31
JIB
II III
Figure 1: Alignment of amino acid sequences of some representatives of the GP82 family. Sequences are encoded by cDNA clones isolated
from T. cruzi metacyclic trypomastigotes: 5.4G6 (ABR19835); CO3 (ABO28970); R31 (AF128843); J18 (AAA21303). GenBank accession
numbers are in parentheses. Potential initiator methionines (M) and a predicted N-amino terminal signal peptide are indicated in red and
green, respectively.The Asp boxes (bacterial sialidase motifs) are boxed and indicated by Roman numerals II and III.The epitope forMab3F6
(P3), mammalian cell binding sites (P4 and P8), and gastric-mucin binding site (P7) are boxed and indicated by different colors. Note the
overlapping between P3 and P4 sites, and P7 and P8 sites.The subterminal VTVmotif, characteristic of the TS superfamily, and the potential
GPI-anchor sequence are shaded in yellow and magenta, respectively. The arrow denotes the cleavage site for GPI anchor addition.
heat inactivated T. cruzi metacyclic forms [3, 4]. Since the
determination of the first GP82 gene sequence in 1994
[9] many other sequences have become available [10–14],
including those from T. cruzi genome sequencing projects
[15–17]. The original analysis by Araya et al., 1994, showed
the presence of two highly conserved Asp box domains
(SxDxGxTW), previously described in bacterial sialidases,
and a subterminal (VTVxNVFLYNR) motif (Figure 1) that
are characteristics of the trans-sialidase (TS) superfamily of
T. cruzi [18]. For this reason GP82 was classified in the TS
superfamily [9, 18].
Figure 2 shows the comparison of five GP82 sequence
variants isolated in our laboratory by cDNA cloning and
three genomic sequences of cloneCLBrener (T. cruzi genome
project). Although all variants code for a glycosylphos-
phatidylinositol (GPI) anchor addition signal sequence at
the carboxy-terminal (C-terminal), several of them do not
have a signal peptide sequence at the amino-terminal (N-
terminal), suggesting that they are not translocated into the
endoplasmic reticulum (ER) and do not receive the GPI
anchor.
Among the sequences annotated as GP82, the cDNA
clone 5.4G6 (GenBank: EF154827) represents a complete
transcript including the 5󸀠 and 3󸀠 untranslated regions
(UTRs) (Figures 1 and 2) [12].This clone encodes a protein of
726 amino acids (GenBank: ABR19835) that reacts with the
Mab3F6 (Figure 1) [12]. The open reading frame (ORF) has
three ATG initiation codons in the same reading frame, but
only the third codon is inserted within the Kozak sequence
context (Figure 2) [12]. It has been proposed that the Kozak
sequence (consensus: GCCRCCaugG, R designates a purine
base and aug the initiation codon), located upstream of the
initiation codon, facilitates the mRNA translation [19]. Fur-
thermore, clone 5.4G6 encodes an N-terminal signal peptide
of 27 amino acids located just after the third methionine
at position 39 and a signal sequence for cleavage/addition
of GPI anchor at the C-terminal (Figures 1 and 2). Taking
into account that the third ATG initiation codon follows the
consensus Kozak sequence and the encoded protein has a
predicted signal peptide, it is presumed that the translation
initiates at the third methionine (Figure 2). The presence of
2-3 initiation codons in the same reading frame is relatively
common among T. cruzi surface proteins, and after the
second or the third methionine there is a sequence encoding
a cryptic signal peptide as described in many genes as GP85
[20], Tc85 [21], ASP-2 [22], CRP-10 [23], GP90 [24], and SAP
[25].
The existence of GP82 sequences lacking a typical N-
terminal signal peptide suggests that its products may be
located intracellularly, as occurs with the GP82 encoded by
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Figure 2: The modular architecture of GP82 family. (a) Structure of GP82 core proteins deduced from cDNA and genomic sequences.
Sequences from cDNA clones are listed in the legend of Figure 1. SL (ABR19836) is a truncated cDNA sequence obtained by RT-PCR. The
slashes indicate that sequence is interrupted. For ease of viewing, the putative C-terminal was drawn in the same line. GenBank accession
numbers are in parentheses.The genomic sequences (GeneBank: XP 811683, XP 810614, XP 811916)were from theT. cruzi genome sequencing
project (clone CL Brener). Potential initiator methionines (M), predicted N-amino terminal signal peptide (SP), and potential GPI-anchor
sequence are indicated in red, gray, and black, respectively. Not drawn to scale. (b) Alignment of GP82 sequences showing the variation of
N-terminal region. Potential initiator methionines (M) are indicated in red and the predicted N-amino terminal signal peptide (PS) is boxed.
cDNA sequences: ABR19835, clones 4, 9, 16, IK10 and 27, ABR19835, ABR19836; genomic sequences were extracted from the T. cruzi genome
sequencing project (clone CL Brener) and are indicated by the prefix XP .
the clone C03 (Figure 1) which is located at the flagellum
of metacyclic forms of the CL strain [13]. Such GP82 pro-
tein displaying flagellar localization is not involved in the
invasion of mammalian cells by metacyclic forms [13]. Data
obtained with monospecific anti-GP82 antibodies support
the hypothesis that GP82 proteins that have no N-terminal
signal peptide are located intracellularly and are not involved
in host cell invasion [13].
Themembers of TS superfamily show a highly conserved
hydrophobic sequence (M S R R V F/T S V L L L L F/L
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V) at the N-terminal region, which acts as a signal peptide
addressing the nascent protein into the ER. Analysis of
the N-terminal region of the CRP-10 from TS superfamily
indicates that this sequence functions as signal peptide
[23]. Based on the analysis of GP82 variants characterized
to date, we could suggest that metacyclic trypomastigotes
simultaneously express different variants of GP82, and their
cellular localization is determined by the N-terminal signal
peptide. However, as the N-terminal of native GP82 has not
been determined, we cannot rule out the possibility that the
translation starts in different ATG codons.
The epitope recognized by Mab3F6 and the site of adhe-
sion of GP82 to the host cells were identified by incubating
recombinant proteins and synthetic peptides in mammalian
in vitro invasion assays. Regions of GP82 gene coding for the
C-terminal, central, andN-terminal domains were subcloned
into plasmid pGEX and expressed in E. coli. The reactivity
with Mab3F6 and the ability of each recombinant protein to
inhibit cell invasion were tested [6], both the Mab3F6 (P3)
binding site and the host cell adhesion sites (P4 and P8) were
identified in the central domain of GP82 (Figure 1) as will be
discussed in the topic below.
3. Organization of GP82 Gene Family
T. cruzi genome comprises more than 50% of repetitive
sequences including several multigene families that encode
surface proteins. Among them, the most abundant is the TS
superfamily [17]. The genome sequencing of clone CL Brener
[17] confirmed the complexity of the TS superfamily by
identification of 1,430 sequences, including 737 genes and 693
pseudogenes. These sequences have been annotated as trans-
sialidase in the T. cruzi genome project with no mention to
which group or family they could be included.
According to sequence identity, molecular weight, and
function,members of TS superfamily were classified into four
groups or families [18, 26–29]. Members of a family or group
exhibit ≥60% similarity among each other, whereas similarity
among members of different families or groups may vary
from 20 to 40%. Group I of the TS superfamily comprises
proteins with enzymatic activity; that is, they are enzymes
(trans-sialidase) able to transfer sialic acid from a donor to
the mucins present at T. cruzi surface [18, 26–29].
Themembers of group II were also called “trans-sialidase
like” proteins because they have no enzymatic activity [18,
26–29]. These proteins have complete or degenerate Asp
box motifs (SxDxGxTW), the VTVxNVFLYNR motif char-
acteristic of all TS members, and the signal sequence for
cleavage/addition of GPI anchor at the C-terminal region
[18, 26–29]. Group II comprises the surface glycoproteins
GP85, Tc85, TSA-1, SA85, GP90, GP82, ASP-1, and ASP-2
which are involved in adhesion and invasion of mammalian
cells [18, 20–22, 24, 26–30]. Several proteins of this group
are also targets of the host immune system and may induce
protective immunity in animal models [30]. The proteins of
group III (CRP, FL160, CEA, and TESA) inhibit the classical
and alternative pathways of complement activation and are
recognized by sera from patients with Chagas disease [18,
26–29, 31, 32]. Group IV is composed of genes encoding
trypomastigote surface antigens that have no defined biolog-
ical function [18, 26, 27].
Recently, Freitas et al., 2011, [33] reported an extensive
and detailed analysis of TS sequences of clone CL Brener that
resulted in the redistribution ofmembers in 8 different groups
designated as TcSgroupI to TcSgroupVIII. The sequences
analyzed in this study (𝑛 = 508) were categorized according
to structure, function, presence of conserved motifs, chro-
mosomal localization, expression profiling, and antigenic
properties. TcSgroupI to TcSgroupIV (𝑛 = 176) correspond
to groups I to IV described above.There is a good correlation
with the classification proposed previously [18, 26, 27] and
with the prior annotation made in our laboratory [16]. The
new classification proposed by Freitas et al., 2011, [33] could
categorize 329 sequences that were included in the groups
TcSgroupV–TcSgroupVIII.
To identify the repertoire of GP82 genes in the genome
of clone CL Brener (the reference clone of T. cruzi Genome
Project), we carried out a BLASTP search using the GP82
encoded by clone 5.4G6 (GenBank: ABR19835) as query [10].
We identified 19 complete sequences with >60% identity with
the query which were considered as GP82 and distributed
as follows: 2 proteins (GenBank: XP 811663 and XP 804688)
with 70–81% identity and the remaining with 61–68% identity
(see Figure 2). Pseudogenes and truncated sequences were
discarded from the analysis. Although GP82 are encoded
from a relatively small number of genes, the repertoire is quite
variable. This contrasts with other TS-like protein families
which are composed of large sets of genes such as GP85, Tc85,
GP90, and ASP [16, 20, 21, 24, 33].
The ability of genes to be robust tomutations at the codon
level has been suggested as a key factor for understanding
adaptation features. It has been proposed that genes relevant
to host-parasite interactionswill tend to exhibit high volatility
or “anti-robust” patterns, whichmay be related to the parasite
capacity of evading the host immune system [34]. We inves-
tigated the potential capacity of T. cruzi surface protein genes
tomaximize phenotypic variation, whichmay be seen as a key
attribute to expand the repertoire of surface antigens [34].The
robustness of a parasite gene againstmutationswas addressed
in terms of several gene volatility and diversity indicators.The
potential impact of point-mutation errors on surface antigen
genes based on the analysis of codon usage and its potential
for generating different amino acid mutants were explored.
These data were consistent with the low rate of volatility
calculated using the GP82 sequences deposited in GenBank
[16]. GP82 genes have “low volatility” which means that the
mutations are generally synonymous or lead replacing amino
acids with others of the same polarity. GP82 genes seem to
be genetically “robust”; that is, they exhibit a tendency to
neutralize the mutations encoding the same amino acid or an
amino acid of the same polarity.
Analysis of selective pressure on GP82 variants showed
that the protein could have undergone conservative or neg-
ative selection. The function of GP82 as adhesin in host
cell invasion process could expose the protein to an intense
conservative and selective pressure. The potential variability
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of GP82 genes suggests that they are “robust” or are not
susceptible to mutation [16].
In the human protozoan parasites Trypanosoma brucei
and Plasmodium falciparum, the subtelomeric regions play
an important role in generation of new variants of surface
antigen genes and in the control of gene expression [35–
37]. We reported that T. cruzi subtelomeric regions are
enriched in (pseudo)genes from the TS superfamily, DGF-1,
and retrotransposon hot spot protein (RHS) families [38, 39].
The abundance of surface protein genes in the subtelomeric
regions suggests that these regionsmay have acted as a site for
DNA recombination, expansion, and the generation of new
variants of surface proteins. Moraes Barros et al. (2012) [39]
demonstrated that all the groups of the TS superfamily are
represented in the subtelomeric regions of clone CL Brener;
most of the sequences (𝑛 = 83) are members of group II
(GP82, GP85, TC85), which includes 22 complete genes. It is
interesting to note that 7 out of 19 GP82 genes identified in
clone CL Brener are located at subtelomeric regions.
4. Synthesis and Processing of GP82
GP82 is attached to the outer parasite’s cell membrane by a
GPI anchor [3, 40]. It is synthesized as a 70 kDa precursor
devoid of N-linked sugars and when mature, it has an
apparent molecular weight of 82 kDa. GP82 binds to the
target cell in a dose-dependent and saturable fashion and
reduces the infection of Vero cells by metacyclic forms of CL
and Tulahuen strains by 90 to 97 and 50%, respectively [8].
The immunological screening of a metacyclic cDNA
library with the Mab3F6 allowed the isolation of a 2,140
bp clone, named J18 (GenBank L14824), which encodes a
protein of 516 amino acids containing the functional domains
of GP82 [9]. Analysis of the deduced amino acid sequence
showed the presence of three sialidase domains (two con-
served and one slightly degenerated), a VTV motif, four
putative N-glycosylation sites, and a GPI-anchor addition
signal, which allows us to classify the GP82 in group II of TS
superfamily [9].
Recombinant expression of clone J18 and a series of
step-wise deletions enabled the identification of the domain
involved in the adhesion to the mammalian cells and indi-
rectly, the region containing the epitope for Mab3F6 [6]. A
central region spanning 132 amino acids was identified as the
responsible for the adhesin properties and ten overlapping
peptides encompassing this central domain were synthesized
to further characterize the region. The authors found two
non-contiguous peptides with significant adhesive proper-
ties, named P4 and P8; thus, they speculated about a putative
conformational binding-domain in the native protein, in
which these two peptides would be in close proximity [6].
To further address the adhesin activity of these peptides
(P4 and P8) and to rule out any peptide’s solubility and
conformational artifacts, both peptides were expressed in a
non-adherent microorganism. The expression of GP82 cell
binding peptides P4 or P8 in the fourth surface-exposed
loop of the transmembrane protein LamB of Escherichia coli
conferred the ability to this microorganism to adhere to the
surface of HeLa cells [41]. Between the two populations of
bacteria, those carrying the P4 peptide were almost twice
more efficient to adhere to HeLa cells than the population
expressing the P8. In the same way, the expression of GP82
protein on the outer membrane of non-infective T. cruzi
epimastigotes enabled these non-adherent forms to attach to
the surface of HeLa cells [42].
A more detailed analysis on the central domain of GP82
was performed by Manque et al., 2000, [43] using the same
peptides described above by Santori et al., 1996, [6] and
variants of GP82 lacking the regions corresponding to the
peptides P4 and P8. This strategy allowed the authors to
identify the peptide P3 as the epitope recognized by Mab3F6.
As the peptide P3 has ten amino acids overlapping with the
peptide P4 (cell binding site), this finding provided support
for the inhibition of parasite’s invasion by Mab3F6, which is
probably due to sterical hindrance. Additionally, the authors
were able to confirm the GP82 conformational cell-binding
domain hypothesis raised by Santori et al., 1996, [6] bymeans
of the hybrid peptide P4/8 which contained 17 amino acids
from P4 and 5 amino acids from P8 peptide. This peptide
P4/8 was more efficient than P4 and P8 peptides to inhibit
the binding of the recombinant GP82 to the HeLa cells [43].
Recently, it was demonstrated thatGP82 binds specifically
to gastricmucin in the oral infection [44, 45].The implication
of GP82 in adhesion of metacyclic forms to the gastric mucin
was first described by Neira et al., 2003, [45] and further
confirmed by Staquicini et al., 2010, [44] using a GP82
recombinant protein Del-4/8 lacking the central domain of
the molecule. The GP82 binding to the gastric mucin may
direct the adhesion and invasion of the stomach epithelium
by the metacyclic forms. Tests of invasion inhibition of the
gastric mucosa showed that peptide P7 (Figure 1), located in
the central domain of the molecule, contains the binding site
to the gastric mucin [44]. The in vitro inhibitory effect of
peptide P7 was reproducible in vivo in murine model [44].
Experimental evidence of the GP82 GPI-anchor was
given by Cardoso De Almeida & Heise (1993) [40] through
digestion with phosphatidylinositol-specific phospholipase
C (PI-PLC) and phase separation in Triton X-114. Araya
et al., 1994, [9] predicted the putative GP82 GPI-anchor
cleavage/addition site based on the sequence of the clone J18.
Similarly, Ramirez et al., 1999, [14, 46] analyzed inmore detail
the GPI-anchor signal of GP82 and other T. cruzi proteins
and conducting homologous and heterologous expressions of
GP82 in T. cruzi epimastigotes and mammalian cell systems.
Despite the absence of a typical signal peptide in the protein
encoded by the J18 clone, the authors found that T. cruzi
machinery was able to translocate the protein inside the ER
finally deliver it to the parasite’s cell surface (Ramirez et al.,
1999) [14]. On the other hand, when the same protein was
synthesized bymammalian cells, it failed to translocate inside
the ER and accumulated in the cytoplasm, indicating the
requirement for a typical signal peptide. When the required
signal was provided by insertion of the signal peptide from
the influenza virus hemagglutinin, the mammalian cell was
able to translocate theGP82 chimera inside the ER but proved
insufficient to provide expression on the cell surface. These
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findings indicated that the requirements for GPI-anchoring
are different between T. cruzi and mammalian cells [14, 46].
In order to further dissect the requirements for GPI-
anchoring between mammals and T. cruzi, a site-directed
mutagenesis was performed in the GPI cleavage/addition
signal [47]. The putative GPI-anchor acceptor domain deter-
mined by Ramirez et al., 1999, [46] is formed by the amino
acids aspartic (𝜔), glycine (𝜔 + 1), and serine (𝜔 + 2) (DGS)
where the aspartic acid is linked to the GPI-anchor. A single
mutation was introduced changing the aspartic acid to serine
generating the sequence (SGS) which previously proved to
be a feasible signal for GPI anchoring of T. brucei Variant
Surface Glycoprotein (VSG) in mammals [48]. An additional
construct lacking theGPI-anchorwas created and transfected
either in mammalian cells or T. cruzi epimastigotes [47].
Confocal analyses on transfected parasites showed that
the point mutation had no detectable effect on the GPI-
anchoring efficiency [47]. The deletion of the GPI-signal
resulted in a protein that was not anchored but accumulated
in the parasite cytoplasm instead [47]. These findings were
in agreement with those obtained in T. brucei by Bo¨hme
and Cross (2002) [49] where the parasite was able to anchor
several mutated proteins but not those in which the GPI-
anchor signal was deleted. On the other hand, the mam-
malian cells failed to express all the transfected proteins on
the cell surface, even the point mutation which proved to be
functional for GPI anchoring in mammals [48].
Isolation of GPI-anchored proteins can be accomplished
by digestion with enzymes that cleave specifically this struc-
ture as glycosylphosphatidylinositol-specific phospholipase
C (GPI-PLC) or phosphatidylinositol-specific phospholipase
C (PI-PLC). This very simple approach can be hindered by
the presence of acylation in position 6 of the inositol ring
(sometimes the acylation occurs at position 5) due to steric
hindrance.
Due to the presence of the GPI anchor, proteins carrying
this modification acquire an overall hydrophobic behavior.
Based on this property, detergents can be used to con-
centrate/enrich fractions in this particular kind of proteins
by temperature-induced partition. Bordier 1981 [50] first
described the suitability of the detergent Triton X-114 (TX-
114) to concentrate hydrophobic proteins due to its nearly
physiological clouding point temperature. At temperatures
above 23∘C a formerly homogenous solution containing
the detergent TX-114 will split into two phases: an upper
layer depleted of detergent (hydrophilic) and a lower phase
enriched in detergent’s micelles (hydrophobic). Using this
physical property, Cordero et al., 2009, [51] concentrated
the GPI-anchored proteins of metacyclic and epimastigotes
of T. cruzi after several consecutive partitions in TX-114.
Mass spectrometry analyses on those fractions detected
several members of TS superfamily, among those, the surface
glycoprotein GP82 had 22% of its sequence covered by tryptic
peptides. Among those peptides, theAsp boxes, VTV, and cell
binding site P8 were mapped [51]. Other important region
mapped in this study was peptide P7, which was identified
as the binding site for the gastric mucin [44].
Several proteomics studies have been conducted in meta-
cyclic forms of T. cruzi, but to the best of our knowledge,
there is only one additional report of GP82 elsewhere [52].
Recently, a quantitative proteomic study was performed
in parasites undergoing metacyclogenesis [53]. Among the
proteins identified in this study, authors found 38 members
of TS superfamily. Due to lack of a unified/standardized
annotation among the databases and the absence of the
peptide sequences used in this study, it was not possible to
determine the presence of GP82 among them. Some of those
annotated TSs shared a high degree of identity with GP82
protein, but because of the missing peptide sequences it is
impossible to assign an unambiguous classification. The lack
of a common nonredundant annotation represents an issue
that must be taken in consideration with an urge to amend.
Recently, Cortez et al., 2012, [54] compiled all the
biochemical, physicochemical, and functional information
available on GP82 in order to create the most updated model
of the protein structure. The authors based this model on the
homology of T. cruziGP82 (GenBank: L14824) withT. rangeli
sialidase (PDB 1N1T A), a close related molecule which
had its crystallographic structure (inhibitor-bound) already
solved. The sketched GP82 appears as two clearly different
and separated domains (an amino-terminal 𝛽-propeller and
a 𝛽-sandwich C-terminal domain) linked together by an 𝛼-
helix. In this layout, P3, P4, P7, and P8 motifs have a variable
degree of access to the solvent. The cell-binding peptide
P4 encompasses 2/3 of the 𝛼-helix that bridges the protein
together and is fully exposed. On the other hand, peptide P8
located in the carboxy-terminal domain, although exposed,
has limited solvent accessibility. The partial exposure of the
P8 motif complies with the experimental data and gives a
topological explanation for the limited role of P8 in the GP82
binding to the cell [41]. As expected, the P3 motif containing
the epitope for the 3F6 antibody was fully exposed and
accessible to the solvent, reinforcing the Mab3F6 inhibitory
effect by steric hindrance. The gastric mucin-binding motif
P7was poorly exposed,mostly due to its high hydrophobicity.
The amino-terminal residues of thismotif (P7) are completely
buried, leaving just the C-terminal portion partially exposed,
mainly because it overlapswith the P8motif. In summary, this
model seems to fulfill the requirements for structural analysis
and provides an appropriated support to the biological
experimental data.
5. Post-Transcriptional Control Mechanisms
of GP82 Expression
In trypanosomes, post-translational controlmechanisms play
an important role in gene expression regulation due to unique
features related to transcription, mRNA maturation, and
stabilization over the parasite life cycle. T. cruzi genome
is organized in large gene clusters separated by divergent
strand-switch regions [55], and transcription of these clus-
ters produces large primary transcripts that are processed
by trans-splicing and polyadenylation to generate mature
mRNAs [56]. These processes are guided by pyrimidine-
rich regions contained in the polycistronic transcripts [57,
58]. Although there is no transcription regulation in T.
cruzi, proteomic analysis of the four developmental stages
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(epimastigote, metacyclic trypomastigote, amastigote, and
bloodstream trypomastigote) demonstrated that there was a
significant change in relative protein abundance throughout
life cycle [52]. Furthermore, microarray analysis showed that
at least 50% of T. cruzi genes are regulated during its life cycle
[59]. GP82 is one of these differentially regulated proteins,
and the mechanisms regulating its stage-specific expression
began to be clarified.
Steady-state levels of GP82 transcripts from T. cruzi G
strain were determined by northern blot, dot-blot hybridiza-
tion, and quantitative real-time PCR, demonstrating that
there is a significant increase in GP82 mRNA levels in
metacyclic forms when compared with the other three stages
[9, 11, 60]. Northern blot analysis revealed a single band
of 2.2 kb mRNA only in metacyclic forms [9]. Dot-blot
hybridization showed thatGP82 transcript levelswere around
5.5-fold higher in metacyclic trypomastigotes than in other
stages [60]. Similar results were obtained using quantitative
real-time PCR (unpublished data). Moreover, expression
analysis of other three GP82 gene subfamilies from Peru-
2 strain, called groups A, B, and C, showed an increase in
mRNA accumulation (4.7 to 9.3-fold) in metacyclic forms
when compared to epimastigotes [11]. Additionally, GP82
protein stage-specific expression was also showed by western
blot using the Mab3F6 [3]. Even though GP82 mRNA and
protein were barely detected in epimastigotes, nuclear run-
on analysis demonstrated that GP82 gene was transcribed
in both epimastigote and metacyclic forms, confirming that
transcript accumulation in metacyclic forms is not due to
an increased transcription rate, but rather to some post-
translational control [60].
Changes in GP82 mRNA stability were detected and
thought to be responsible for differences in its steady-state
level. Parasites treated with actinomycin D had their GP82
transcript half-lives estimated to be about 6 h in metacyclic
forms and 0.5 h in epimastigotes [60]. Cycloheximide treat-
ment increased GP82 levels in epimastigotes, suggesting
that a labile protein factor was responsible for destabilizing
mRNA in these forms and prevent mRNA translation. In
addition, GP82 mRNAs were only found associated with
polysomes inmetacyclic forms [60], indicating that transcript
mobilization to polysomes might be involved in regulating
GP82 expression, as was reported for another T. cruzi gene
[61].
There are at least three known factors that modu-
late mRNA steady-state level: cis-acting elements, trans-
acting factors, and the apparatus involved in mRNA
turnover and degradation [62]. Cis-acting elements are non-
coding sequences that act from inside the same molecule
(intramolecular action). Trans-acting factors are diffuse
molecules, usually proteins, that act from a differentmolecule
to regulate a target mRNA (intermolecular action) [63]. The
fate of transcripts is determined by the interaction of cis-
acting sequences present in the 3󸀠UTR with specific trans-
acting protein factors containing RNA-binding domains that
subsequently recruit the protein machinery to destroy or
stabilize mRNAs [64]. The involvement of GP82 3󸀠UTR in
mRNA stability was analyzed using a reporter green fluo-
rescent protein (GFP) fused upstream to the GP82 3󸀠UTR.
Parasites transfected with an episomal plasmid carrying
this construct had their GFP protein and mRNA levels
analyzed, revealing that the 3󸀠UTR was able to downregulate
GFP in epimastigotes and upregulate it in metacyclic forms
[65]. Similar mechanisms for controlling mRNA stability by
3󸀠UTR sequences have also been described for other TS
family members, such as the flagellum-associated surface
protein FL-160 (TcS group III) [66], two genes coding for
active trans-sialidase enzymes fromTcS group I, described by
Jager et al., 2008, [67], and another TS member [64]. There
are pieces of evidence that stem-loop secondary structures
formed in the 3󸀠UTRmight be responsible for the interaction
with RNA-binding proteins [68]. Prediction of GP82 3󸀠UTR
secondary structure was performed in silico using mfold
program [69], revealing the presence of stem-loop structures;
however, the role of these structures was not analyzed so far.
Regulatory cis-acting elements of variable sizes were
identified in the 3󸀠UTR of some trypanosomatid genes
(reviewed in [62, 70]). In the case of GP82, four step-wise
deletions were performed to search for regulatory elements
in its 3󸀠UTR. Results indicated that more than one region
was responsible for changing GFP mRNA and protein levels
in epimastigotes and metacyclic forms [65], suggesting that
multiple cis-acting elements are present in GP82 3󸀠UTR and
might bind to distinct RNA-binding proteins (RBP).The first
trans-acting factor identified in T. cruzi was TcUBP1 (T. cruzi
uridine binding protein 1), which binds to AU-rich elements
of the TcSMUG mRNA leading to its destabilization [71].
In addition to TcSMUG, other 39 transcripts were found
bound to TcUBP1 by co-immunoprecipitation assays [68].
One common cis-acting element was identified in the 3󸀠UTRs
of the majority of these TcUBP1 target mRNAs. This cis-
element was used to predict novel UBP1 target mRNAs and
GP82 was one of them [68]. Therefore, TcUBP1 could be one
of the trans-acting factors involved in GP82 mRNA stability.
A schematic representation of the mechanism controlling
GP82 gene expression is shown in Figure 3.
There are growing pieces of evidence suggesting the pres-
ence of post-transcriptional operons in trypanosomes, medi-
ated by the coordinated interaction between cis-elements and
trans-acting factors [68, 72]. It was demonstrated that a group
of T. brucei stage-regulated proteins share a specific sequence
motif in the 3󸀠UTR (reviewed in [72]). Also, two RBPs from
T. cruzi, TcUBP1, and TcUBP3, preferentially associate with
a set of functionally related transcripts bearing the same
RNA motif that is recognized by each protein [68]. These
post-transcriptional operons could explain how coordinately
expression regulation is achieved in organisms where gene-
specific transcriptional control is absent.
6. Concluding Remarks and Perspectives
GP82 shows a modular organization, with some variation of
N-terminal region flanking a conserved central core where
the binding sites to mammalian cell and gastric mucin are
located.The function of GP82 as adhesin in host cell invasion
process could expose the protein to an intense conservative
and selective pressure. The potential variability of GP82
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Figure 3: Comparison of GP82 mRNA post-transcriptional control mechanisms in (a) epimastigotes and (b) metacyclic trypomastigotes.
In epimastigotes, GP82 mRNA interacts with possibly more than one RNA-binding protein (RBP), which binds to different cis-elements in
the 3󸀠UTR region (small black rectangles), leading to mRNA destabilization and decay. Conversely, in the metacyclic trypomastigote stage, a
different set of RBPs interacts with the cis-elements present in the 3󸀠UTR, promoting mRNA stabilization and translation in polysomes.
genes suggests that they are not susceptible to mutation.
The many isoforms of GP82 and its multiple N-terminal
variants suggest that some GP82 family members might
display different cellular localizations and functions. The
challenge is to ascertain the relationships betweenGP82 gene
sequences, protein isoforms, and its distinct or overlapping
functions.
GP82 is a GPI-anchored surface protein, synthesized as a
70 kDaprecursor devoid ofN-linked sugars andwhenmature
has an apparentmolecular weight of 82 kDa. GPI-minus vari-
ants accumulate in the ER indicating that GPI anchor acts as
a forward transport signal for progressing along the secretory
pathway as suggested for T. cruzi mucins [73]. Heterologous
expression of GP82 into mammalian cells indicated that the
requirements for GPI-anchoring are different between T.
cruzi andmammalian cells.These differences could be targets
for the development of parasite-specific therapeutic agents.
Several studies demonstrated that the transcription
of GP82 is constitutive and may be regulated at post-
transcriptional level, for instance, at translational level
and/or mRNA stabilization. GP82 mRNAs are mobilized
to polysomes and consequently translated, but only in
metacyclic trypomastigotes. It has been suggested that the
stabilizing mechanism acting in metacyclic trypomastigotes
and the destabilizing mechanism in epimastigotes could be
mediated by a cis-acting element present in the 3󸀠UTR of
transcripts. A series of step-wise deletions in the 3󸀠UTR was
created and results suggest that the mechanism regulating
GP82 expression involves multiple elements in the 3󸀠UTR.
Interestingly, the 3󸀠UTR of GP82 transcript promotes higher
expression of the green fluorescent protein (GFP) reporter in
metacyclic trypomastigotes than in epimastigotes.
In conclusion, while our knowledge of the structure and
function of GP82 is large, there still remainmany questions to
be answered. Additional studies are carried out to analyze the
expression, localization, and involvement in host cell invasion
of each GP82 variant identified to date.
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